Search
Login
Register
Menu
BJH
Home
News
CongressUpdate
Guidelines
Specials
Links
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
News
>
Pharma News
>
New haematology reimbursement in Belgium: axicabtagene ciloleucel (Yescarta
®
) for second line DLBCL
New haematology reimbursement in Belgium: axicabtagene ciloleucel (Yescarta
®
) for second line DLBCL
November 2023
Pharma News
Ariez
To view this article please log in on top of screen and belong to the target group of this article
.
Share this article
Share
Tweet
Share
Email
Share
Top
